Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Soeren_Mueller
    Junior Member
    • Jul 2011
    • 1

    #1

    miRBase - Why do they not keep name conventions?

    Hi,

    according to the name conventions in miRBase, closely realted-but not similar- mature miRNAs should be named like miR-121a and miR-121b.

    " Lettered suffixes denote closely related mature sequences "

    Why does this not hold true for plant miRNAs?
    I work with medicago and for medicago there are a bunch of mature miRNAs with the same sequence.. For example:

    >mtr-miR2593a MIMAT0013280 Medicago truncatula miR2593a
    TTAAATGAATGAACCTAGAAT
    >mtr-miR2593b MIMAT0013281 Medicago truncatula miR2593b
    TTAAATGAATGAACCTAGAAT
    >mtr-miR2593c MIMAT0013282 Medicago truncatula miR2593c
    TTAAATGAATGAACCTAGAAT

    They have different PRECURSOR sequences but the mature sequence is completely the same. Does this make any sense at all? If you perform an experiment like sRNA-Seq you will only see the mature form and wont be able to identify the precurosr it was derived from anyway.

    Do you have any idea why people from miRBase do not stick to their own rules here?

    Cheers

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...